1/119
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai |
|---|
No analytics yet
Send a link to your students to track their progress
Lymphoproliferative disorders
Represent a group of clonal disorders that originate from cells of the lymphoreticular system.
Leukemia
When the neoplastic cells involve mainly the bone marrow and the blood, the disorder is known as:
Lymphoma
When the disease is limited mainly to lymph nodes or organs, the disease is known as:
Leukemia
Occasionally, a lymphoma can develop into a ___ when the cells of the diseased organ spreads to the bone marrow and then to the blood.
Peripheral smear findings, Bone marrow aspirate studies, CBC findings
Lymphoproliferative disorders can be detected through:
Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia, Hairy Cell Leukemia
Lymphoproliferative disorders MTs should know about
Acute leukemia
Refers to the rapid, clonal proliferation in the bone marrow of lymphoid or myeloid progenitor cells known as lymphoblasts and myeloblasts.
When these blastic proliferations overwhelm the bone marrow, the blasts spill over into the blood and are seen in peripheral smears
Anemia, Thrombocytopenia
The signs and symptoms of leukemia reflect the suppression of normal hematopoiesis by these abnormally proliferating blasts, thus causing ___ and ___ commonly.
Acute lymphoblastic leukemia
ALL meaning
Acute lymphoblastic leukemia
Systemic, neoplastic proliferation of lymphoblasts originating in lymphocyte progenitor cells of the bone marrow or thymus
Acute lymphoblastic leukemia
Most common type of leukemia in pediatric patients
70%
About what % of cases of ALL occurs in patients under 17 years of age?
2-10
What age is ALL most common in?
Rare
ALL frequency in adults
25-41%
ALL cure rate in adults; has poorer outlook
60%
ALL cure rate if response to treatment is good
Unknown
ALL etiology
Radiation
Children exposed to ___ in utero or at a young age appear to have an increased incidence of ALL
Genetic factors
These presumably play a role in some cases of ALL
Acute myeloid leukemia
The presenting signs and symptoms of ALL are similar to those of ___ and are usually related to blood cytopenias
Immunophenotyping techniques
T-cell ALL and B-cell ALL are primarily differentiated by:
Flow cytometry, Immunohistochemistry
Methods to what cell surface markers are present on the proliferating neoplastic lymphoblasts.
B-cell ALL
Type of ALL
Lymph node enlargement is often found.
T-cell ALL
Type of ALL
There may be a large mass in the mediastinum leading to compression of regional anatomic structures.
B-cell ALL
Type of ALL
Splenomegaly & hepatomegaly less so but may also be present.
Anemia, Thrombocytopenia, Organomegaly, Bone pain
Symptoms present in both B-cell and T-cell ALL
T-cell ALL
Type of ALL that present Anemia, Thrombocytopenia, Organomegaly, and Bone pain to a lesser degree
World Health Organization classification
ALL classification that emphasizes the immunophenotype and cytogenetic findings, which have more clinical and prognostic relevance than morphology
20%
World Health Organization classification for ALL
A finding of at least (how much %) blasts in the bone marrow is required for diagnosis of majority of acute leukemias and testing must be done to detect the presence or absence of genetic abnormalities.
World Health Organization classification
ALL classification that is not a very popular classification because only very specialized laboratories are able to perform cytogenetic testing.
7
B-cell ALL amount of subtypes associated with recurrent cytogenetic abnormalities which are linked with unique clinical or prognostic features.
French-American-British classification
ALL classification that more popular
L1, L2, L3
French-American-British ALL classification
Subtypes
French-American-British classification
ALL classification that more popular based on morphologic examination to distinguish lymphoblasts from myeloblasts.
ALL-3
French-American-British ALL classification
Subtype with: Large, homogenous cell population. Nuclei regular with fine chromatin and 1- 2 nucleoli. Moderate to abundant vacuolated cytoplasm
ALL-1
French-American-British ALL classification
Subtype with: Small uniform cell. Nuclei regular with condensed chromatin, inconspicuous nucleoli. Scant cytoplasm.
ALL-2
French-American-British ALL classification
Subtype with: Large, heterogenous cell population. Nuclei irregular / clefting with occasional nucleoli. Mild to moderate cytoplasm.
80-88%
French-American-British ALL classification
What % of pediatric ALL cases are L1?
8-18%
French-American-British ALL classification
What % of pediatric ALL cases are L2?
1-5%
French-American-British ALL classification
What % of pediatric ALL cases are L3?
35-40%
French-American-British ALL classification
What % of adult ALL cases are L1?
60%
French-American-British ALL classification
What % of adult ALL cases are L2?
1-5%
French-American-British ALL classification
What % of adult ALL cases are L3?
CBC, PBS, BM aspiration, Trephine biopsy morphologic exam, Appropriate cytochemical studies on blood and bone marrow, Immunophenotyping of leukemic blasts by flow cytometry, Immunohistochemistry, BM cytogenetic studies, Molecular studies as indicated, CSF examination, Radiographic studies for assessment of extramedullary mass disease as indicated, Other biochemical and microbiologic studies as indicated
Tests for diagnosing ALL
90%
% of ALL patients with abnormal blood counts
Bicytopenia, Pancytopenia
Blood cell interpretation in ALL (Either of the 2 answers)
Anemia
Most common blood cell finding in ALL
Normochromic, Normocytic
ALL PBS finding
Decreased
ALL reticulocyte count (Qualitative answer)
25%
% of ALL patients present leukopenia in the low normal range
50%
% of ALL patients that have WBC counts between 5-25x10^9/L
10%
% of ALL patients that have WBC counts >100x10^9/L
Lymphoblasts
ALL WBC present in blood smears for majority of patients, including most who present with leukopenia.
Atypical lymphocytes
Lymphocytes that display paler staining areas in the nucleus that are easily confused as nucleoli (often confused with blasts because of their fairly large cells and rich basophilic cytoplasm).
Reduced
ALL Neutrophil count (Qualitative answer)
Neutropenia
ALL
Rate of infection parallels the severity of the ___
Lymphoblast, myeloblast morphology
First tool to distinguish ALL from AML
Large, often uniform
AML blast size
Usually finely dispersed
AML nuclear chromatin
1-4, often prominent
AML nucleoli
Moderately abundant, granules often present
AML cytoplasm
Present in 60-70% of cases
AML Auer rods
Myeloblasts
AML cells
Variable, small to medium
ALL blast size
Coarse to fine
ALL nuclear chromatin
Absent or 1-2, often indistinct
ALL nucleoli
Usually scant, coarse granules sometimes present 7%
ALL cytoplasm
Not present
ALL Auer rods
Lymphoblasts
ALL cells
Small, Large
Lymphoblast 2 morphological types
Small lymphoblast
Lymphoblast morphologic type
Nucleus & Cytoplasm: Scant blue cytoplasm, indistinct nucleoli
Large lymphoblast
Lymphoblast morphologic type
Size: 2 to 3x the size of a normal lymphocyte
Large lymphoblast
Lymphoblast morphologic type
Nucleus & Cytoplasm: Prominent nucleoli, nuclear membrane irregularities
Small lymphoblast
Lymphoblast morphologic type
Most common
Small lymphoblast
Lymphoblast morphologic type
Size: 1 to 2.5x the size of a normal lymphocyte
Large lymphoblast
Lymphoblast morphologic type
Easy to confuse with myeloblasts in acute myeloid leukemia
Lymphoblasts
ALL BM smears are hypercellular and consist mostly of:
Markedly reduced
ALL
Amount of normal hematopoietic cells
Sparsely scattered, Overrun the bone marrow space
ALL
Lymphoblasts distribution in the bone marrow
Decreased
ALL
Amount of RBC, granulocytic cells, megakaryocytes, PLT ct, Absolute neutrophil ct (Qualitative answer)
Infection, Bleeding, Pale, Fatigue, Tachycardia
Typical presentation of patients with ALL
Infection
Presentation of patients with ALL because:
They have little neutrophils to fight off the infection.
Bleeding
Presentation of patients with ALL because:
Due to thrombocytopenia.
Tachycardia
Presentation of patients with ALL because:
Due to anemia
Immunophenotyping, Genetic analysis
Most reliable indicators of a cell's origin.
CD34, TdT, HLA-DR
Surface markers common to both B and T cells
Terminal deoxynucleotidyl transferase
TdT meaning
CD19, 20, 22, 24, 79a, 10, Cytoplasmic u, PAX-5
B cell cell markers
CD2, 3, 4, 5, 7, 8
T cell cell markers
Cytochemical stains
Primarily to help distinguish ALL from AML.
Cytochemical stains
Procedure that is useful in determining whether a cell in question is a lymphoblast, an atypical lymphocyte, or a large granular lymphocyte,
Negative
Lymphoblast result for myeloperoxidase
Positive
Myeloblast result for myeloperoxidase
Brown
Myeoblast granule color in Cytochemistry stain
Positive
Periodic acid-Schiff stain result in most cases of ALL
Periodic acid-Schiff stain
This cytochemical stain is distributed in coarse granules or clumps in the cytoplasm corresponding to glycogen deposits.
ALL-L3
ALL classification according to FAB classification that stains positively with Oil Red O stain.
Vacuole
What specific component of cells are stained positively with Oil Red O stain in ALL?
Terminal deoxynucleotidyl transferase
Unique DNA polymerase found normally in a small number of bone marrow lymphoid cells
5-10%
% of AML positive for TdT, less than ALL